Sabrina K. Glavota

SABRINA GLAVOTA focuses her practice on complex corporate matters, with an emphasis on mergers, acquisitions, and private equity transactions in addition to strategic partnerships centered around licensing and collaboration. She represents companies in the life sciences and agribusiness and food industries. 

During her time in law school, Sabrina served as associate editor of Vol. 27 and articles editor of Vol. 28 of the Michigan Technology Law Review. She was a student attorney with both the Pediatric Advocacy Clinic, providing direct legal aid to low-income families, and the Zell Entrepreneurship Clinic, providing corporate counseling to local startups regarding intellectual property matters and corporate governance. Sabrina also held the position of the mentorship chair of the Women Law Students Association as well as vice president of the Intellectual Property Students Association.

Prior to law school, Sabrina received her undergraduate degree in biochemistry and worked in an academic microbiology research lab investigating E. coli cell division proteins as potential targets in future development of antibiotics.

Sabrina has assisted with the representation of:

• Tata Consumer Products (NYSE: TATACONSUM) in its acquisition of food and beverage company Organic India.
• TowerBrook Capital Partners L.P. in its majority equity investment in Demakes Enterprises, LLC.
• Chong Kun Dang Corp. (CKD) in a potentially US$1.3 billion out-licensing of its proprietary therapeutic to Novartis AG, granting Novartis the rights to develop and commercialize CKD-510, an HDAC6 inhibitor.
• Crown Bioscience in its acquisition of the IndivuServ business unit of Indivumed GmbH.

• Member, Women Lawyers Association of Los Angeles

• Sabrina is part of Sidley’s Emerging Enterprises Pro Bono Program where she advises small for-profit and non-governmental organizations in Africa on corporate and intellectual property matters.